Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in Ischemic Stroke
NCT02535611Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Oct 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of memantine in ischemic stroke, sponsored by Mazandaran University of Medical Sciences. Started Oct 2015; status: completed.
02
Drugs
memantine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02535611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02535611.